-+ 0.00%
-+ 0.00%
-+ 0.00%

Core Laboratories Sees Q4 GAAP EPS $0.12-$0.20 vs $0.17 Est; Sees Sales $128.500M-$134.500M vs $133.317M Est

Benzinga·10/28/2026 20:25:19
Listen to the news
Core Laboratories (NYSE:CLB) is looking for Q4 GAAP EPS of $0.12-$0.20 vs $0.17 analyst estimate. sees sales of $128.500 million-$134.500 million vs $133.317 million analyst estimate.